Post-traumatic Stress Disorder (PTSD) is a pathological response to trauma that 27 impacts ~8% of the population and is highly comorbid with other disorders, such as 28 Traumatic Brain Injury (TBI). PTSD affects multiple biological systems throughout the 29 body, including the hypothalamic-pituitary-adrenal axis (HPA-axis), cortical function, and 30 the immune system, and while the study of the biological underpinnings of PTSD and 31 related disorders are numerous, the roles of non-coding RNAs (ncRNAs) are just 32 emerging. Moreover, deep sequencing has revealed that ncRNAs represent most of the 33 transcribed mammalian genome. Here, we present developing evidence that ncRNAs 34 are involved in critical aspects of PTSD pathophysiology In that regard, we summarize 35 the roles of three classes of ncRNAs in PTSD and related disorders: microRNA 36 (miRNA), long-noncoding RNA (lncRNA), and retrotransposons. The review evaluates 37 findings from both animal and human studies with a special focus on the role of ncRNAs 38 in HPA-axis abnormalities and glucocorticoid dysfunction in PTSD and TBI. We 39 conclude that ncRNAs may prove to be useful biomarkers that facilitate personalized 40 medicines for trauma-related brain disorders. definition is not rooted in biology, yet molecular (5, 6) and circuit-defined (7, 8) subtypes 52 have been proposed, elucidating its biological heterogeneity. Historically regarded as a 53 brain disease, PTSD affects whole body health (9, 10) and its effects can potentially be 54 measured peripherally (e.g. blood). In pursuit of biomarkers and a deeper 55 understanding of PTSD pathophysiology, the role of non-coding RNAs (ncRNAs) is 56 prime for exploration and should be studied together with alterations in coding RNAs 57
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association with inflammation. Third, downregulation of miR-3130-5p in PTSD across 230 two independent populations was reported (68). Fourth, an additional study revealed 231 190 dysregulated miRNAs in PTSD subjects, many with comorbid depression, vs. 232 controls (69). Fifth, miR-21 upregulation in veterans with PTSD was reported in a non-233 miRNA specific microarray study (70) . Amongst these studies, miR-15b downregulation 234 was reported by two studies (66, 67). miR-15b is also associated with multiple cancers 235 (71), is a potential biomarker for Alzheimer's Disease (72), which is interesting as PTSD 236 increases risk for dementia (73), and is involved in GC-signaling (see below). The 237 divergent results above may be due to differences in study design andassays, but also 238 inadequate statistical power due to relatively small sample sizes (74) . 239 DICER1 expression decreases in PTSD (68), perhaps related to the increased 240 vulnerability described in the animal model above (43), leading to lower concentrations 241 of miRNAs in cases versus controls overall when measured via RNA-sequencing. 242
Supporting this, the majority of PTSD blood-based miRNA studies report reduced 243 miRNA expression in PTSD (Table 3) . Reduced DICER1 expression levels are also 244 associated with positive affect (75), indicative of the cross-disorder role of DICER1 and 245 possible reduced miRNA concentration across multiple psychiatric disorders (75). 246
Functionally, miRNAs regulate post-transcriptional gene expression, and while any 247 single miRNA's influence is small, the overall reduction in miRNAs may lead to 248 "decreased buffering" of gene expression, allowing large fluctuations in transcript levels 249 and downstream protein expression, potentially permitting pathogenic processes to take 250 over. 251 252
PTSD and TBI comorbidity 253
PTSD is highly comorbid with depression and mild-TBI (mTBI) (76). For an 254 overview of miRNAs in PTSD and depression, we refer readers to a recent review (77) . 255 mTBI is a head injury leading to brief loss of consciousness and changes in mental 256 status that can lead to headaches, sleep disruption, and neurocognitive symptoms, 257 sometimes lasting years. Many mTBI symptoms overlap with aspects of PTSD (78). 258
Notably, PTSD and TBI are frequently studied in parallel in military cohorts but generallyM A N U S C R I P T
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are not considered together in civilian studies. For instance, only two of the five PTSD 260 miRNA studies discussed above reported TBI status of subjects. 261 mTBI patients with neurocognitive deficits exhibited an overall decrease in 262 miRNA expression (79), similar to PTSD studies described above. The downregulation 263 of 4 of 13 miRNAs was replicated in an independent sample of mTBI patients with 264 neurocognitive deficits (80). Notably, both cases and controls could be PTSD positive, 265 and the signature was not translatable to TBI alone. Another hallmark of PTSD and 266 mTBI is dysregulation of the HPA-axis (81). Taheri and colleagues explored predictors 267 of hypopituitarism in TBI subjects, as determined by low cortisol levels in acute TBI 268 cases, and found two miRNAs systematically up-regulated at multiple time points (82) . 269
Notably, peri-traumatic low cortisol is associated with higher risk for PTSD (81). Given 270 how closely related hypo-cortisol levels are to both PTSD and TBI-associated 271 hypopituitarism, it is possible that the identified miRNAs are also suggestive of PTSD 272 risk. Supplemental Table S1 www.google.com/patents/US20140073524). Current data is difficult to interpret due to a 279 few factors. Firstly, studies are underpowered, and power is critical for robust results. 280
Collaborative, large, well-powered discovery studies of miRNAs and other blood based 281 biomarkers are necessary to uncover reliable, reproducible hits for translation into 282 clinically significant biomarkers. Secondly, it is difficult to compare across miRNA 283 studies because different blood preparations and assays were used. For instance, 284 PTSD studies primarily use whole blood while TBI studies focus on cell-free portions of 285 blood. Understanding which blood fractions exhibit the best signal to noise for abnormal 286 miRNA measurement is key. Moreover, understanding which miRNAs are highly 287 expressed in dysfunctional neural circuits in PTSD and mTBI post-mortem brains, will 288 elucidate biological mechanisms and reveal putative biomarkers to measure in the cell-289 free portions of blood. Lastly, biomarker studies are correlational, and must be validated 290 M A N U S C R I P T
through functional studies. A key divide between preclinical and human studies is the 291 divergence in tissues of study -preclinical studies generally focus on brain tissues while 292 human research is limited to blood. Bridging between the two spheres by pursuing 293 animal studies of brain and blood and then pursuing brain-enriched candidate markers 294 in human studies, may lead to biomarkers of PTSD pathophysiology. 295 296
LncRNA 297
Most lncRNAs are RNA species characterized by polyadenylation, splicing of 298 multiple exons, promoter trimethylation of histone H3 at lysine 4 (H3K4me3), and 299 transcription by RNA polymerase II (83). LncRNAs are transcripts that lack protein-300 coding potential, characterized by the presence of open-reading frame length >100 301 amino acids. Although generally lncRNAs are generated and processed in the nucleus, 302 most lncRNAs function in the cytoplasm, but some operate in the nucleus such as XIST 303 (X inactive specific transcript) (83, 84). Functional conservation across species (Table  304 1) is emerging to be a key feature of lncRNAs, akin to protein-coding genes (83, 85, 86) . 305
To date, less than 50 lncRNAs have been functionally characterized, most in the context 306 of cancer (87). These examples provide the foundational landscape of lncRNA-307 mediated biology, and its implications in a variety of processes, including differentiation, 308 apoptosis, development, and neurogenesis (88). 309
The role of lncRNAs in trauma-related mental disorders remains poorly 310 characterized, despite their high expression in the brain (89). Here, we review the 311 limited evidence of lncRNAs association with stress and PTSD-like disorders in animal 312 and human studies (Tables 2 & 3) . 313 314
LncRNAs in animal studies 315
In 2015, two studies reported a correlational link between lncRNAs and PTSD-like 316 syndromes in rats (90) and mice (91). 317
Microarray analysis in rats exposed to stress enhanced fear learning (SEFL), a 318 
Retrotransposons 370
Transposable elements comprise roughly 45% of the human genome, and over 371 90% of these are retrotransposons (102). Transposons are a class of genomic elements 372 capable of moving (transposing) themselves around the genome. Retrotransposons 373 transpose via a copy and paste mechanism using RNA intermediates. 374
Retrotransposons are further subdivided into three major taxa: the long interspersed 375 nuclear elements (LINEs), the short interspersed nuclear elements (SINEs), and the 376 endogenous retrovirus/long terminal repeat class (ERV/LTR) (103). Transposons were 377 initially described as "controlling elements" (104), appearing to be responsive to 378 stressful events (105). 379
With the capacity to transpose as defining feature of retrotransposons, they are 380 commonly transcribed and provide a diversity of regulatory RNA motifs. Most lncRNAs 381 derive form transposons, which have little impact on protein coding sequence (106). 
Putative role of ncRNAs in GR-signaling in PTSD 412
Given that stress is, by definition, implicated in the development of PTSD, the 413 primary stress-systems, the fight-or-flight autonomic system, and the HPA-axis haveM A N U S C R I P T
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been a natural target of biological studies of PTSD, as reflected in the previous 415 sections. PTSD was initially assumed to be a response to extreme or prolonged trauma 416 with the expectation of increased levels of the major stress mediators, catecholamines 417 (CAs) and GCs (81). However, PTSD epidemiology revealed that traumatic events are 418 common (2) . 419
Against expectation, PTSD patients displayed low basal cortisol, and an 420 exaggerated HPA-axis GR-mediated negative feedback (Figure 2A Specific miRNAs can affect GR-signaling by reducing GR protein levels or sensitivity to 51
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GCs, leading to a reduced translocation of GC-bound GR to the nucleus. LncRNAs 52 interfere with the nuclear binding of GR to DNA sites, by providing alternative sites for 53 binding. These "decoy" GREs "mimic" the sequence of consensus GRE (mGRE). It 54 should be noted that the proposed model in not relevant to a specific tissue type in the 55 brain or in the periphery. For instrance the other corticosteroid receptor, the 56 mineralocorticoid receptor (MR) is not included. MR does not always co-localize with 57 GR since MR is present in specific brain regions like the hippocampus and specific 58 peripheral tissues like the kidney, while GR is more abundant. Additionally, the other 59 members of the GR complex might also be regulated by ncRNAs. Adapted from (150). pre-miRNA
